GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. (WGS) is a healthcare company (diagnostics & research) based in the United States. The share price is $45.44, down 10.94% on the day, which values the company at $1.36B. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$45.44−10.94% today
Market value
$1.36B
Forward P/E
34.9×
Funk Score
53/100
Against its own history
About its usual priceusual price $50.29
200-week average
$54.1816% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

GeneDx Holdings Corp. in more detail

WGS trades at 34.9× next year's expected earnings, 3.0× sales. Measured against its own history, the price is 10% below what its usual multiples would imply ($50.29) — about its usual price. It sits 16% below its 200-week average of $54.18.

Over the last five fiscal years GeneDx Holdings Corp. has compounded revenue 19.0% a year. Its Funk Score is 53 out of 100 (financial strength 5.6, profitability 2.3, growth 9.2, value 4.0, each out of 10).

In its favour: Operating margin is expanding; More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

3 of the superinvestors tracked here hold WGS, including Keith Meister (10.2% of the portfolio), Cathie Wood (0.8% of the portfolio), Karthik Sarma (0.0% of the portfolio).

Superinvestors holding WGS

3 of the investors tracked here report a position in their latest 13F filing.

GeneDx Holdings Corp. (WGS): questions and answers

What is GeneDx Holdings Corp.'s market cap?

GeneDx Holdings Corp. is valued at $1.36B at a share price of $45.44.

Is WGS overvalued or undervalued?

Against its own history, WGS is about its usual price: the price is 10% below the $50.29 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is WGS above its 200-week moving average?

No. WGS is 16.1% below its 200-week average of $54.18. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is GeneDx Holdings Corp. growing?

Over the last five fiscal years GeneDx Holdings Corp.'s revenue grew 19.0% a year.

Does WGS pay a dividend?

GeneDx Holdings Corp. does not currently pay a regular dividend.

Which famous investors own WGS?

In their latest quarterly filings, Keith Meister (10.2% of the portfolio), Cathie Wood (0.8% of the portfolio), Karthik Sarma (0.0% of the portfolio) hold WGS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “GeneDx Holdings Corp. (WGS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/WGS

Underlying data: Yahoo Finance; company filings with the SEC.